EXO Biologics

Foundation date

29/08/2019

Sector

#Biotechnology - Therapeutics

Subsector

EXO Biologics is a biotechnology company in Belgium focused on Extracellular Vesicles, Exosomes research and drug development. Our Company's mission is to provide affordable and accessible therapy to patients with unmet medical needs.
Extracellular Vesicles and Exosomes are gaining momentum in the scientific community as potential alternatives to stem cell therapies. This new technology is offering a therapeutic tool that is safer, more effective, and efficient in production when compared to stem cell therapies.

Upcoming events

Latest news

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    14 hours ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022